(CS-051) The use of an acidic debridement agent in combination with Negative Pressure Wound Therapy for the development of granulation tissue in skin ulcers
Co-Author(s):
<b>Introduction</b>: <p class="MsoNormal" style="line-height: 150%;"><span style="font-size: 12.0pt; line-height: 150%; font-family: 'Arial',sans-serif; mso-fareast-font-family: 'Times New Roman'; color: black; mso-themecolor: text1; mso-ansi-language: EN-US; mso-fareast-language: NL;">Most skin ulcers heal by secondary intention</span><span style="font-size: 12.0pt; line-height: 150%; font-family: 'Arial',sans-serif; color: black; mso-themecolor: text1; mso-ansi-language: EN-US;"><sup><span style="mso-no-proof: yes;">1</span></sup></span><span style="font-size: 12.0pt; line-height: 150%; font-family: 'Arial',sans-serif; color: black; mso-themecolor: text1; mso-ansi-language: EN-US;"> but progress is hampered by the presence of necrosis and biofilm. Therefore, debridement is necessary to remove these detrimental factors. </span></p> <p class="MsoNormal" style="line-height: 150%; mso-pagination: none;"><span style="font-size: 12.0pt; line-height: 150%; font-family: 'Arial',sans-serif; mso-fareast-font-family: 'Times New Roman'; color: black; mso-themecolor: text1; mso-ansi-language: EN-US; mso-fareast-language: NL;">A new debriding agent (TDA) contains <a name="_Hlk49852584"></a><span style="border: none windowtext 1.0pt; mso-border-alt: none windowtext 0cm; padding: 0cm;">an acidic species in a gel. The agent has a potent hygroscopic action</span></span><span style="mso-bookmark: _Hlk49852584;"><span style="font-size: 12.0pt; line-height: 150%; font-family: 'Arial',sans-serif; mso-fareast-font-family: 'Times New Roman'; color: black; mso-themecolor: text1; border: none windowtext 1.0pt; mso-border-alt: none windowtext 0cm; padding: 0cm; mso-ansi-language: EN-US; mso-fareast-language: NL;"><sup><span style="mso-no-proof: yes;">2</span></sup></span></span><span style="mso-bookmark: _Hlk49852584;"><span style="font-size: 12.0pt; line-height: 150%; font-family: 'Arial',sans-serif; mso-fareast-font-family: 'Times New Roman'; color: black; mso-themecolor: text1; border: none windowtext 1.0pt; mso-border-alt: none windowtext 0cm; padding: 0cm; mso-ansi-language: EN-US; mso-fareast-language: NL;"> and causes swift desiccation, oxidation and denaturation of microorganisms and tissues: in earlier publications it was shown that the use of TDA leads to rapid formation of granulation tissue, necessary for healing by secondary intention. </span></span></p> <p class="MsoNormal" style="line-height: 150%; mso-pagination: none;"><span style="font-size: 12.0pt; line-height: 150%; font-family: 'Arial',sans-serif; color: black; mso-themecolor: text1; mso-ansi-language: EN-US;">Negative pressure wound therapy (NPWT) has also been shown to support the development of granulation. </span></p><br/><br/><b>Methods</b>: <p class="MsoNormal" style="line-height: 150%; mso-pagination: none;"><span style="font-size: 12.0pt; line-height: 150%; font-family: 'Arial',sans-serif; color: black; mso-themecolor: text1; mso-ansi-language: EN-US;">A clinical evaluation was conducted to assess whether the combination of TDA with NPWT would be beneficial. </span></p><br/><br/><b>Results</b>: <p class="MsoNormal" style="line-height: 150%;"><span style="font-size: 12.0pt; line-height: 150%; font-family: 'Arial',sans-serif; color: black; mso-themecolor: text1; mso-ansi-language: EN-US;">Twelve patients (10 female, average age 77.9 years) with lesions on the lower leg participated. Five ulcers were venous in origin, two were arterial, one was of mixed venous/arterial origin, and one was post-trauma (unknown: N=3). The average size was 308 cm<sup>2</sup> (60-1750). The lesion’s average age was 13,2 months (4-48). All patients suffered from one or more significant comorbidities. <span style="mso-spacerun: yes;"> </span></span></p> <p class="MsoNormal" style="line-height: 150%;"><span style="font-size: 12.0pt; line-height: 150%; font-family: 'Arial',sans-serif; color: black; mso-themecolor: text1; mso-ansi-language: EN-US;">TDA was applied once, and NPWT (at -125 mmHg) was used immediately after the procedure, for a period of one week. </span></p> <p class="MsoNormal" style="line-height: 150%;"><span style="font-size: 12.0pt; line-height: 150%; font-family: 'Arial',sans-serif; color: black; mso-themecolor: text1; mso-ansi-language: EN-US;">All patients reached complete granulation in, on average, 13,2 weeks (7-21). There were no side effects of either treatment. </span></p><br/><br/><b>Discussion</b>: <p class="MsoNormal" style="line-height: 150%;"><span style="font-size: 12.0pt; line-height: 150%; font-family: 'Arial',sans-serif; color: black; mso-themecolor: text1; mso-ansi-language: EN-US;">The combination of TDA-NPWT was shown to support the rapid development of granulation tissue in a series of serious ulcers (given their size and age) and, thus, supports healing by secondary attention. </span></p><br/><br/><b>Trademarked Items</b>: <br/><br/><b>References</b>: 1. Zitelli J. Wound healing for the clinician. Adv Dermatol 1987;2:243-67. [published Online First: 1987/01/01] 2. Bignozzi AC, Cogo A, Carinci F. Compositions for removing necrotic or infected tissues from body lesions and from oral cavity. . Patent Cooperation Treaty Nr PCT/IB2019/051146 2020;Patent Pending<br/><br/>